following post-transplant GI events compared with no dosage modification. Methods: Adult renal transplant recipients with a … complications is associated with significantly increased risk of graft failure and increased healthcare costs in adult renal … transplant recipients. DOI: 10.2165/0019053-200826110-00007 …

People receiving a renal transplant require long-term treatment with immunosuppressant drugs. Contemporary regimens …

: To assess direct healthcare costs for de novo renal transplant recipients in the US receiving branded versus generic CsA … linked to the Organ Procurement and Transplantation Network data. A total of 227 renal transplant cases between 1996 and 2004 …: Despite initial perceived cost savings associated with generic CsA, de novo renal transplant recipients incurred greater total …

primary prevention of graft rejection in renal transplant recipients in the UK. Methods: A stochastic simulation model was … tacrolimus for the primary prevention of graft rejection in renal transplant recipients in the UK. Sirolimus was economically …

. Methods: Long-term costs and outcomes in adherent and non-adherent renal transplant patients were simulated in a Markov model … death in adherent and non-adherent renal transplant patients were derived from literature. Results: Compared with dialysis … transplantation. The low incremental cost per QALY calculated in this model for adherent renal transplant patients, suggests there may …

saving of $Can1551 during the first year after renal transplant. Although modelling assumptions become more restrictive over …